Department of Health and Human Services$1.1M obligationsEnds Dec 18, 2021
Federal contract award
HHSN272201600015C
IGF::OT::IGF - TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541712 |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $5.6M |
| Current contract value | $5.6M |
| Potential contract value / ceiling | $5.6M |
| Start date | Jul 1, 2016 |
| Current end date | Dec 31, 2025 |
| Potential end date | Dec 31, 2025 |
| Latest award activity | Dec 10, 2024 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 18 of 18 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Dec 10, 2024 | P00017 | $-3.6K | TO CONDUCT A CLINICAL TRIAL TO EVALUATE THE EFFICACY OF A PATIENT-COLLECTED DRIED BLOOD SPOT CMV PCR TESTING PLATFORM IN AN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION. |
| Jul 18, 2024 | P00016 | $0 | TO CONDUCT A CLINICAL TRIAL TO EVALUATE THE EFFICACY OF A PATIENT-COLLECTED DRIED BLOOD SPOT CMV PCR TESTING PLATFORM IN AN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION. |
| Jul 15, 2024 | P00015 | $0 | TO CONDUCT A CLINICAL TRIAL TO EVALUATE THE EFFICACY OF A PATIENT-COLLECTED DRIED BLOOD SPOT CMV PCR TESTING PLATFORM IN AN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION. |
| Feb 28, 2024 | P00014 | $0 | TO CONDUCT A CLINICAL TRIAL TO EVALUATE THE EFFICACY OF A PATIENT-COLLECTED DRIED BLOOD SPOT CMV PCR TESTING PLATFORM IN AN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION. |
| Jan 3, 2024 | P00013 | $237.5K | TO CONDUCT A CLINICAL TRIAL TO EVALUATE THE EFFICACY OF A PATIENT-COLLECTED DRIED BLOOD SPOT CMV PCR TESTING PLATFORM IN AN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION. |
| Jun 9, 2023 | P00012 | $0 | TO CONDUCT A CLINICAL TRIAL TO EVALUATE THE EFFICACY OF A PATIENT-COLLECTED DRIED BLOOD SPOT CMV PCR TESTING PLATFORM IN AN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION. |
| Nov 16, 2022 | P00011 | $-2.1K | TO CONDUCT A CLINICAL TRIAL TO EVALUATE THE EFFICACY OF A PATIENT-COLLECTED DRIED BLOOD SPOT CMV PCR TESTING PLATFORM IN AN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION. |
| Jun 21, 2022 | P00010 | $0 | TO CONDUCT A CLINICAL TRIAL TO EVALUATE THE EFFICACY OF A PATIENT-COLLECTED DRIED BLOOD SPOT CMV PCR TESTING PLATFORM IN AN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION. |
| Feb 15, 2022 | P00009 | $1.1M | TO CONDUCT A CLINICAL TRIAL TO EVALUATE THE EFFICACY OF A PATIENT-COLLECTED DRIED BLOOD SPOT CMV PCR TESTING PLATFORM IN AN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION. |
| Oct 22, 2021 | P00008 | $0 | EO14042 - TO CONDUCT A CLINICAL TRIAL TO EVALUATE THE EFFICACY OF A PATIENT-COLLECTED DRIED BLOOD SPOT CMV PCR TESTING PLATFORM IN AN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION. |
| Aug 23, 2021 | P00007 | $-13.0K | TO CONDUCT A CLINICAL TRIAL TO EVALUATE THE EFFICACY OF A PATIENT-COLLECTED DRIED BLOOD SPOT CMV PCR TESTING PLATFORM IN AN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION. |
| Dec 3, 2020 | P00006 | $0 | TO CONDUCT A CLINICAL TRIAL TO EVALUATE THE EFFICACY OF A PATIENT-COLLECTED DRIED BLOOD SPOT CMV PCR TESTING PLATFORM IN AN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION. |
| Jun 4, 2020 | P00005 | $1.5M | TO CONDUCT A CLINICAL TRIAL TO EVALUATE THE EFFICACY OF A PATIENT-COLLECTED DRIED BLOOD SPOT CMV PCR TESTING PLATFORM IN AN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION. |
| Sep 23, 2019 | P00004 | $0 | TO EXTEND THE COMPLETION DATE OF OPTION ONE TO DECEMBER 31, 2020 AT NO ADDITIONAL COST AND ADD FAR CLAUSES 52.204-25 AND 52.244-6. |
| Nov 7, 2017 | 2 | $1.3M | OPTION ONE. 11/07/2017 - 11/06/2019. TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS. |
| Apr 18, 2017 | 1 | $0 | IGF::OT::IGF - TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS |
| Jul 1, 2016 | 0 | $1.5M | IGF::OT::IGF - TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS |
| Jul 1, 2016 | 3 | $0 | OPTION ONE. 11/07/2017 - 11/06/2019. TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.